Photo taken from LUNGevity Foundation/X
Jun 1, 2024, 21:10
LUNGevity Foundation – Subcutan injection or IV infusion for EGFR + NSCLC
LUNGevity Foundation shared a post on X:
“Subcutan injection or IV infusion? Does it matter? Phas 3 PALOMA-3 says it might. Researchers studied ami + oral laz in patients with adv EGFR + NSCLC for drug effic and safety. Manual subcutan injections had better PFS, DoR and pat convenience.”
Source: LUNGevity Foundation/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 05:18
Feb 22, 2025, 05:15
Feb 22, 2025, 05:05
Feb 22, 2025, 04:54
Feb 22, 2025, 04:49
Feb 22, 2025, 04:33
Feb 22, 2025, 04:29
Feb 22, 2025, 04:19